Dr. Apter at the CINP

Dr. Apter discussed ‘breakthroughs & controversies in mood, psychosis, schizophrenia, ADHD, and insomnia’ at the 2019 CINP International Meeting. It took place on October 3-5 at Royal Olympic Hotel in Athens, Greece.

The 2019 CINP International Meeting expanded on the 2017 Prague Meeting on Treatment-Resistant Depression and extend the program to a wider field of psychiatry. The event brought together the field professionals from all over the globe and became a wonderful platform for sharing expertise and networking.

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2019 Global Clinical Trials, LLC

All rights reserved.